Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGLS Regulus Therapeutics Inc

休市中 11-22 16:00:00 EST

1.47

+0.07

+5.00%

盘后1.51

+0.04+2.72%

19:24 EST

最高1.48	最低1.37	成交量28.80万
今开1.44	昨收1.40	日振幅7.86%
总市值9,629万	流通市值7,153万	总股本6,550万
成交额41.49万	换手率0.59%	流通股本4,866万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":1.47,"timestamp":1732309200000,"preClose":1.4,"halted":0,"volume":288016,"hourTrading":{"tag":"盘后","latestPrice":1.51,"preClose":1.47,"latestTime":"19:24 EST","volume":4342,"amount":6345.3168,"timestamp":1732321440099},"delay":0,"floatShares":48662433,"shares":65500134,"eps":-0.92479,"marketStatus":"休市中","marketStatusCode":7,"change":0.07,"latestTime":"11-22 16:00:00 EST","open":1.44,"high":1.48,"low":1.37,"amount":414886.70238080004,"amplitude":0.078571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.92479,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1349323200000,"adjPreClose":1.4,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.4,"latestTime":"09:25 EST","volume":6018,"amount":8541.559233599999,"timestamp":1732285500050},"postHourTrading":{"tag":"盘后","latestPrice":1.51,"preClose":1.47,"latestTime":"19:24 EST","volume":4342,"amount":6345.3168,"timestamp":1732321440099},"volumeRatio":1.087003,"impliedVol":0.1944,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/RGLS/tweets","defaultTab":"tweets","newsList":[{"id":"2485218114","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485218114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485218114?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:59","pubTimestamp":1732301958,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时59分，Regulus Therapeutics Inc.股票出现波动，股价快速上涨5.00%。截至发稿，该股报1.47美元/股，成交量16.4735万股，换手率0.25%，振幅6.79%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025918abd7fd2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025918abd7fd2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2485411416","title":"Regulus Therapeutics Inc.盘中异动 早盘快速跳水6.07%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485411416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485411416?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:05","pubTimestamp":1732205152,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时05分，Regulus Therapeutics Inc.股票出现异动，股价大幅下跌6.07%。截至发稿，该股报1.32美元/股，成交量5.7704万股，换手率0.09%，振幅2.50%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112200055298e43f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112200055298e43f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2483130601","title":"Regulus Therapeutics Inc.2024财年第三财季实现净利润-14.06百万美元，同比减少79.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483130601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483130601?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Regulus Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-14.06百万美元，同比减少79.80%；其中营业收入为0.00美元，每股基本收益为-0.21美元。从资产负债表来看，Regulus Therapeutics Inc.总负债6.96百万美元，其中短期债务764000.00美元，资产负债比为13.48，流动比率为13.66。机构评级：截至2024年11月16日，当前有6家机构对Regulus Therapeutics Inc.目标价做出预测，其中目标均价为10.33美元，其中最低目标价为3.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316abc51604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316abc51604&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ"],"gpt_icon":0},{"id":"2483060433","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.33%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483060433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483060433?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:55","pubTimestamp":1731686122,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时55分，Regulus Therapeutics Inc.股票出现异动，股价急速跳水5.33%。截至发稿，该股报1.42美元/股，成交量9.0578万股，换手率0.14%，振幅6.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为3.55%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235522971a6e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235522971a6e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2482573452","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.44%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573452?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:48","pubTimestamp":1731340113,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时48分，Regulus Therapeutics Inc.股票出现异动，股价大幅跳水5.44%。截至发稿，该股报1.39美元/股，成交量13.8238万股，换手率0.21%，振幅6.12%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111234833971a5c1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111234833971a5c1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2481161719","title":"Regulus Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481161719","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481161719?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:19","pubTimestamp":1731032394,"startTime":"0","endTime":"0","summary":"Regulus Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Regulus Therapeutics Inc RGLS.OQ报告，截至9月30日的季度调整后每股亏损21美分，高于去年同期的每股-40美分。六位分析师对该季度的平均预期是每股亏损 17 美分。Regulus Therapeutics Inc 报告的季度每股收益为亏损 21 美分。该公司当季亏损 1406 万美元。Regulus Therapeutics Inc 本季度股价下跌了 3.8%，今年迄今为止上涨了 18.0%。华尔街对 Regulus Therapeutics Inc 的 12 个月目标价中位数为 7.50 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF07P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGLS"],"gpt_icon":0},{"id":"2481988383","title":"Regulus Therapeutics Inc  预计每股亏损 17 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988383","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988383?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903558,"startTime":"0","endTime":"0","summary":"Regulus Therapeutics Inc  预计每股亏损 17 美分 - 财报前瞻Regulus Therapeutics Inc RGLS.OQ RGLS.O预计在11月7日公布截至2024年9月30日的财报时，季度营收将不会有任何变化(预计) LSEG分析师对Regulus Therapeutics Inc的平均预期为每股亏损17美分。华尔街对 Regulus Therapeutics Inc 的 12 个月目标价中位数为 7.50 美元，高于上一次收盘价 1.49 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD2M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLS"],"gpt_icon":0},{"id":"2479863031","title":"Regulus Therapeutics Inc.盘中异动 快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479863031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479863031?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:47","pubTimestamp":1730386027,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时47分，Regulus Therapeutics Inc.股票出现异动，股价急速下跌5.13%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为3.55%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Mimedx Group, Inc、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为241.65%、230.15%、162.34%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Vaccinex, Inc.，振幅分别为46.15%、39.30%、37.72%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031224707ab8bed57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031224707ab8bed57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2478438275","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨6.60%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478438275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478438275?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:18","pubTimestamp":1730128698,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时18分，Regulus Therapeutics Inc.股票出现异动，股价急速上涨6.60%。截至发稿，该股报1.54美元/股，成交量16.4311万股，换手率0.25%，振幅4.86%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823181898e3ede9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823181898e3ede9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS"],"gpt_icon":0},{"id":"2477559681","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.03%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477559681?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:48","pubTimestamp":1729702105,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时48分，Regulus Therapeutics Inc.股票出现异动，股价急速下跌5.03%。截至发稿，该股报1.42美元/股，成交量8.6915万股，换手率0.13%，振幅5.03%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400482598e3e0ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400482598e3e0ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2476056943","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476056943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476056943?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:59","pubTimestamp":1729094391,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时59分，Regulus Therapeutics Inc.股票出现波动，股价快速拉升5.29%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6335.91%、1099.23%、939.89%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为633.55%、279.52%、196.43%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016235952a1e123af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016235952a1e123af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2474097932","title":"Regulus Therapeutics Inc.盘中异动 快速拉升5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474097932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474097932?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:14","pubTimestamp":1728656053,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时14分，Regulus Therapeutics Inc.股票出现异动，股价大幅上涨5.06%。截至发稿，该股报1.50美元/股，成交量2.6443万股，换手率0.04%，振幅4.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101122141398e3be4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101122141398e3be4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2473848416","title":"Regulus Therapeutics Inc.盘中异动 下午盘股价大涨5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473848416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473848416?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:15","pubTimestamp":1728324939,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时15分，Regulus Therapeutics Inc.股票出现异动，股价大幅上涨5.06%。截至发稿，该股报1.66美元/股，成交量12.0436万股，换手率0.18%，振幅4.31%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080215399719eb44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080215399719eb44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2472574647","title":"Regulus Therapeutics Inc.盘中异动 快速上涨5.70%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472574647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472574647?lang=zh_cn&edition=full","pubTime":"2024-10-03 01:19","pubTimestamp":1727889567,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日01时19分，Regulus Therapeutics Inc.股票出现波动，股价大幅拉升5.70%。截至发稿，该股报1.67美元/股，成交量63.7106万股，换手率0.97%，振幅8.16%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410030119279719e00e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410030119279719e00e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2472330532","title":"Regulus Therapeutics Inc.盘中异动 快速跳水5.59%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472330532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472330532?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:28","pubTimestamp":1727720929,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时28分，Regulus Therapeutics Inc.股票出现波动，股价快速跳水5.59%。截至发稿，该股报1.52美元/股，成交量5.4666万股，换手率0.08%，振幅5.59%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010228509719da60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010228509719da60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2469142448","title":"Regulus Therapeutics Inc.盘中异动 大幅下跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469142448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469142448?lang=zh_cn&edition=full","pubTime":"2024-09-24 00:28","pubTimestamp":1727108922,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日00时28分，Regulus Therapeutics Inc.股票出现异动，股价快速下挫5.49%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为293.27%、61.74%、61.16%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为74.90%、57.08%、45.45%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409240028439719c407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409240028439719c407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2469606361","title":"Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469606361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469606361?lang=zh_cn&edition=full","pubTime":"2024-09-21 03:59","pubTimestamp":1726862352,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日03时59分，Regulus Therapeutics Inc.股票出现异动，股价急速上涨5.26%。截至发稿，该股报1.80美元/股，成交量80.6291万股，换手率1.23%，振幅8.60%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.51%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409210359129719c11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409210359129719c11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2461874921","title":"Regulus Therapeutics Inc.盘中异动 急速拉升5.03%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461874921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461874921?lang=zh_cn&edition=full","pubTime":"2024-08-22 02:02","pubTimestamp":1724263326,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日02时02分，Regulus Therapeutics Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报1.67美元/股，成交量21.7861万股，换手率0.33%，振幅6.92%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822020207a1d57a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822020207a1d57a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2460004440","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨6.33%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004440","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004440?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:31","pubTimestamp":1724160701,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时31分，Regulus Therapeutics Inc.股票出现异动，股价快速拉升6.33%。截至发稿，该股报1.68美元/股，成交量1756股，换手率0.00%，振幅1.58%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021314298e35833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021314298e35833&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2460241025","title":"Regulus Therapeutics Inc.2024财年第二财季实现净利润-11.04百万美元，同比减少57.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241025","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241025?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824037,"startTime":"0","endTime":"0","summary":"8月17日，Regulus Therapeutics Inc.公布财报，公告显示公司2024财年第二财季净利润为-11.04百万美元，同比减少57.49%；其中营业收入为0.00美元，每股基本收益为-0.17美元。从资产负债表来看，Regulus Therapeutics Inc.总负债5.94百万美元，其中短期债务747000.00美元，资产负债比为0.18，流动比率为18.48。机构评级：截至2024年8月17日，当前有6家机构对Regulus Therapeutics Inc.目标价做出预测，其中目标均价为10.33美元，其中最低目标价为3.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000558959f2d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000558959f2d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":-0.0667},{"period":"1month","weight":-0.0604},{"period":"3month","weight":-0.209},{"period":"6month","weight":-0.3069},{"period":"1year","weight":0.0769},{"period":"ytd","weight":0.0937}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.成立于2007年9月6日。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对microRNA的一流药物，以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":-0.016722},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.00374},{"month":3,"riseRate":0.5,"avgChangeRate":0.090028},{"month":4,"riseRate":0.25,"avgChangeRate":-0.057759},{"month":5,"riseRate":0.583333,"avgChangeRate":0.084394},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.119338},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.130856},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.042258},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.004778},{"month":10,"riseRate":0.166667,"avgChangeRate":0.026008},{"month":11,"riseRate":0.384615,"avgChangeRate":0.04635},{"month":12,"riseRate":0.416667,"avgChangeRate":0.0557}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}